$67.76 2.4%
EW Stock Price vs. AI Score
Data gathered: November 17

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Edwards Lifesciences (EW)

Analysis generated October 24, 2024. Powered by Chat GPT.

Edwards Lifesciences Corporation is a prominent American medical equipment company. Renowned for its innovative heart valve products, it primarily designs, manufactures, and markets technologies for structural heart disease, especially in relation to critical care and surgical monitoring. The company’s key product lines include transcatheter heart valves, surgical heart valves, and critical care products. With a focus on heart-related medical devices, Edwards Lifesciences serves a critical role in the healthcare sector and sees steady demand for its life-saving technologies.

Read full AI stock Analysis

Stock Alerts - Edwards Lifesciences (EW)

company logo Edwards Lifesciences | November 14
Insider Alert: BOBO DONALD E JR is selling shares
company logo Edwards Lifesciences | November 13
Job postings are down by 25.2% in the last couple of days.
company logo Edwards Lifesciences | November 12
Ro Khanna (member of U.S. congress) is buying shares
company logo Edwards Lifesciences | November 5
Job postings are down by 34.4% in the last couple of days.

About Edwards Lifesciences

Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.


Edwards Lifesciences
Price $67.76
Target Price Sign up
Volume 6,390,000
Market Cap $40B
Year Range $59.7 - $95.56
Dividend Yield 0%
PE Ratio 26.16
Analyst Rating 36% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '241.38B717M1.09B3.07B403M0.670
Q2 '241.4B736M1.1B366M404M0.700
Q1 '241.61B875M1.21B352M526M0.660
Q4 '231.49B842M1.18B370M368M0.640
Q3 '231.5B790M993M385M423M0.590

Insider Transactions View All

BOBO DONALD E JR filed to sell 46,936 shares at $65.6.
November 13 '24
Wood Larry L filed to sell 198,526 shares at $65.9.
November 5 '24
BOBO DONALD E JR filed to sell 46,936 shares at $69.5.
October 15 '24
BOBO DONALD E JR filed to sell 46,936 shares at $66.8.
September 11 '24
Chopra Daveen filed to sell 29,333 shares at $70.
August 20 '24

What is the Market Cap of Edwards Lifesciences?

The Market Cap of Edwards Lifesciences is $40B.

What is Edwards Lifesciences' PE Ratio?

As of today, Edwards Lifesciences' PE (Price to Earnings) ratio is 26.16.

What is the current stock price of Edwards Lifesciences?

Currently, the price of one share of Edwards Lifesciences stock is $67.76.

How can I analyze the EW stock price chart for investment decisions?

The EW stock price chart above provides a comprehensive visual representation of Edwards Lifesciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Edwards Lifesciences shares. Our platform offers an up-to-date EW stock price chart, along with technical data analysis and alternative data insights.

Does EW offer dividends to its shareholders?

As of our latest update, Edwards Lifesciences (EW) does not offer dividends to its shareholders. Investors interested in Edwards Lifesciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Edwards Lifesciences?

Some of the similar stocks of Edwards Lifesciences are Boston Scientific, Intuitive Surgical, Medtronic, Stryker, and Becton Dickinson and Co.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.